Monitoring and tracking your progress Objective tracking eliminates guesswork and provides the data needed for informed protocol adjustments
Annual cancer progression risk: 0.5% per person, per year (1 in 200) Five year risk for either HGD or cancer: 1.7% (1 in 59) Cells are beginning to grow abnormally, but not yet likely to become cancerous or spread Grading low-grade dysplasia can be very challenging, and pathologists often do not agree on the diagnosis
Mechanism: GHK-Cu modulates over 4,000 human genes approximately 6% of the human genome
Be Pro for Whey Protein Milk is divided into two proteins, casein protein (making up 80 percent of milk) and whey protein (comprising the remaining 20 percent of milk)
That's a fancy way of saying it's three amino acids bound to a copper ion
Endoscopic eradication therapies If you have cells that are highly abnormal in your tissue sample, or high-grade dysplasia, your doctor may suggest an endoscopic eradication therapy
